Ocular Therapeutix (OCUL) Other Working Capital Changes (2019 - 2026)

Ocular Therapeutix's Other Working Capital Changes history runs 8 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 790.62% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 513.07% increase from a year earlier, with the FY2025 full-year figure at -$128000.0, up 51.15% from the prior year.
• Other Working Capital Changes climbed to $1.8 million in Q1 2026 per OCUL's latest filing, from $128000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $7.0 million in Q3 2024 and bottomed at -$3.9 million in Q1 2025.
• The 5-year median for Other Working Capital Changes is -$81000.0 (2022), against an average of $380058.8.
• Across the five-year window, Other Working Capital Changes soared 820.16% in 2024 and slumped 333.9% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at $1.6 million in 2022, then slumped by 107.78% to -$124000.0 in 2023, then surged by 820.16% to $893000.0 in 2024, then tumbled by 85.67% to $128000.0 in 2025, then surged by 1281.25% to $1.8 million in 2026.
• Per Business Quant, the three latest OCUL Other Working Capital Changes figures stand at $1.8 million (Q1 2026), $128000.0 (Q2 2025), and -$256000.0 (Q1 2025).